This inventor holds 2 USPTO granted patents. Top assignee: Taito Company, Ltd.. Active years: 1980-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1982
Title: Ryousuke Touyama: Innovator in Nitrogen-Containing Monoterpene Derivatives
Introduction
Ryousuke Touyama is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of chemistry, particularly in the development of nitrogen-containing monoterpene derivatives. With a total of 2 patents, his work focuses on creating low toxic and efficient dyestuffs with promising pharmacological effects.
Latest Patents
Touyama's latest patents include innovative compounds that have garnered attention in the scientific community. The first patent details novel nitrogen-containing monoterpene derivatives featuring a pyridine skeleton, along with dimers, trimers, and higher polymers. These compounds are recognized for their low toxicity and efficiency as dyestuffs, with expected pharmacological benefits. The second patent also revolves around nitrogen-containing monoterpene derivatives, synthesized by substituting an oxygen atom in an iridoid skeleton with a nitrogen atom. This approach aims to produce low toxic and efficient dyestuffs, again highlighting their anticipated pharmacological effects.
Career Highlights
Touyama is currently associated with Taito Company, Ltd., where he continues to innovate and develop new chemical compounds. His work has positioned him as a key figure in the field of chemistry, particularly in the synthesis of novel compounds that have practical applications.
Collaborations
Throughout his career, Touyama has collaborated with esteemed colleagues such as Hiroyuki Inouye and Tetsuro Shingu. These collaborations have further enriched his research and development efforts, leading to advancements in the field.
Conclusion
Ryousuke Touyama's contributions to the development of nitrogen-containing monoterpene derivatives demonstrate his commitment to innovation in chemistry. His patents reflect a promising future for low toxic and efficient dyestuffs with potential pharmacological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile